A phase 4 TANDEM trial in the United States evaluated whether ubrogepant for acute migraine treatment can be safely added to atogepant and used daily for preventive therapy in adults with episodic migraine,...
A large cohort study found no significant association between migraines, their subtypes, or frequency and Parkinson disease (PD) risk in women 45 years and older, suggesting migraines may not contribute to...
Results from a recent randomized controlled trial shows that cognitive-behavioral stress management (CBSM) significantly reduces anxiety, depression, and post-traumatic stress disorder in parents of...
The FDA approved the first treatment for patients with congenital thrombotic thrombocytopenic purpura (cTTP), which is a rare and life-threatening blood clotting disorder that may be fatal if left...
A randomized controlled trial in adults with chronic migraine found that 4 weeks of noninvasive vagal nerve stimulation (nVNS) significantly reduced pain intensity, headache frequency, and migraine-related...
Migraine is highly prevalent among women of reproductive age, yet data on real-world medication use around conception remain limited. A new Danish study describes patterns of antimigraine medication use...
A post-hoc analysis of the phase 3 REGAIN trial evaluated whether preventive treatment with galcanezumab could shift patients with chronic migraine to episodic migraine frequency, a clinically meaningful...
